Literature DB >> 30309637

Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.

Edward C Lo1, Adam N Rucker2, Michael P Federle2.   

Abstract

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) comprise the majority of primary liver cancers. Both HCC and ICC have characteristic imaging appearances on multiphase computed tomography (CT) and magnetic resonance imaging (MRI). Several locoregional therapies, including radiation therapy, are used to treat unresectable disease and residual or recurrent tumor. The tumor response following locoregional therapies has variable imaging manifestations. Focal liver reaction, the imaging changes of the liver following radiation treatment, should be recognized and not mistaken for tumor. We review the diagnostic imaging of HCC and ICC, imaging of tumor response to treatment, and imaging of the liver response to radiation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30309637     DOI: 10.1016/j.semradonc.2018.06.010

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  7 in total

1.  Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma.

Authors:  Syed Rahmanuddin; Ronald Korn; Derek Cridebring; Erkut Borazanci; Jordyn Brase; William Boswell; Asma Jamil; Wenli Cai; Aqsa Sabir; Pejman Motarjem; Eugene Koay; Anirban Mitra; Ajay Goel; Joyce Ho; Vincent Chung; Daniel D Von Hoff
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 5.738

Review 2.  [Differential diagnoses of biliary tract diseases : Computed tomography and magnetic resonance imaging].

Authors:  K Lampichler; M Scharitzer
Journal:  Radiologe       Date:  2019-04       Impact factor: 0.635

3.  lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity.

Authors:  Qiao Jin; Hao Hu; Siqi Yan; Long Jin; Yuliang Pan; Xiangjun Li; Yayi Peng; Peiguo Cao
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

4.  Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.

Authors:  Xiaoliang Xu; Yingfan Mao; Yanqiu Tang; Yang Liu; Cailin Xue; Qi Yue; Qiaoyu Liu; Jincheng Wang; Yin Yin
Journal:  Comput Math Methods Med       Date:  2022-02-21       Impact factor: 2.238

5.  Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens.

Authors:  Sho Kitamura; Keita Kai; Mitsuo Nakamura; Tomokazu Tanaka; Takao Ide; Hirokazu Noshiro; Eisaburo Sueoka; Shinich Aishima
Journal:  Cancers (Basel)       Date:  2022-05-05       Impact factor: 6.639

Review 6.  Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.

Authors:  Tingsong Chen
Journal:  J Hepatocell Carcinoma       Date:  2022-09-15

7.  Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.

Authors:  Yiwei Dong; Qianqian Cai; Lisheng Fu; Haojie Liu; Mingzhe Ma; Xingzhong Wu
Journal:  Biomed Res Int       Date:  2021-07-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.